Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-24

Clinical Trial Update: Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a food supplement for preventing urinary tract infections in kidney transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arafarma Group, S.A. | Conditions: Kidney Transplant Infection | Phase 4 | Status: COMPLETED